RITHIM BIOLOGICS®

Rithim Biologics is a privately held, early stage startup company developing gene therapies to treat tachycardias (fast heart rates) in humans.Utilizing gene therapies, our initial efforts are targeting atrial fibrillation (AF) and more specifically those patients at risk for post-operative (cardiac) AF (POAF).POAF has been reported in 27% to 40% of coronary artery bypass graph (CABG) surgery patients.1 Worldwide, approximately 800,000 patients undergo CABG procedures annually.2... Founded in March 2016, Rithim Biologics® is a privately held, early stage startup company developing gene therapies, delivery instruments, and kits to prevent/reduce tachyarrhythmias (fast heart rates) in humans.

Also known as: Rithim Biologics®, Inc.

Primary location: Woodbine